is hair loss a side effect of glp 1 GLP-1 loss: why it happens, what the research shows, and how to protect your hair GLP-1 drugs may be linked

Glia 70 , 519 (2022)

For heart failure or chronic kidney disease, the American Diabetes Association generally recommends SGLT2 inhibitors as first-line agents, with GLP-1 receptor agonists considered for their benefits on atherosclerotic cardiovascular disease, glycemic control, and weight management, or when SGLT2 inhibitors are not appropriate

& Ismail, K

McIntyre, MD: GLP-1 agonists for psychiatry

More recently, in March 2024, Wegovy was This approval followed promising results from novo Nordisks SELECT trial, which followed 17,604 adults with obesity or overweight and cardiovascular disease but no history of diabetes

Researchers say these findings indicate physicians prescribing Wegovy should monitor for signs of blood clots and ensure proper hydration to reduce risks, and caution should be used when prescribing Wegovy to patients with a predisposition to blood clots